advisorsecurities master

ALVOAlvotech Ordinary Shares

CSNasdaq (XNAS)·USD

Identity

Security key
11626
Ticker
ALVO
Type
CSCommon Stock
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
2022-06-16
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
ALVO

Detail

Enriched 2026-08-14 20:47

Market cap
$1,356,261,522.31
Shares outstanding (class)
Shares outstanding (weighted)
338,219,831
SIC
Employees
1,460
Location
Description

Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. The company's commercialized products incldue AVT02, AVT03, AVT04, AVT05, and AVT06. Its pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. Geographically, the company generates the majority of revenue from Europe, and the rest from the USA and the rest of the world.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data